Literature DB >> 18768815

Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission.

Lucia Carvelli1, Randy D Blakely, Louis J DeFelice.   

Abstract

The Caenorhabditis elegans (C. elegans) dopamine (DA) transporter (DAT-1) regulates DA signaling through efficient DA reuptake following synaptic release. In addition to its DA transport function, DAT-1 generates detectable DA-gated currents that may influence neuronal excitability. Previously, we provided evidence that single Cl-channel events underlie DAT-1 currents. In these studies, we identified a distinct population of altered DAT-1 currents arising from DAT-1 transgenic constructs bearing an N-terminal GFP fusion. The presence of these channels suggested disruption of an endogenous regulatory mechanism that modulates occupancy of DAT-1 channel states. A leading candidate for such a regulator is the SNARE protein syntaxin 1A (Syn1A), previously found to interact with homologous transporters through N-terminal interactions. Here we establish that UNC-64 (C. elegans Syn1A homologue) associates with DAT-1 and suppresses transporter channel properties. In contrast, GFP::DAT-1 is unable to form stable transporter/UNC-64 complexes that limit channel states. Although DAT-1 and GFP::DAT-1 expressing DA neurons exhibit comparable DA uptake, GFP::DAT-1 animals exhibit swimming-induced paralysis (SWIP), a phenotype associated with excess synaptic DA release and spillover. We propose that loss of UNC-64/DAT-1 interactions leads to enhanced synaptic DA release, providing a novel mechanism for DA neuron sensitization that may be relevant to mechanisms of DA-associated disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768815      PMCID: PMC2528871          DOI: 10.1073/pnas.0802214105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Association between schizophrenia and the syntaxin 1A gene.

Authors:  Albert H C Wong; Joseph Trakalo; Olga Likhodi; Muneeb Yusuf; Antonio Macedo; Maria-Helena Azevedo; Tim Klempan; Michele T Pato; William G Honer; Carlos N Pato; Hubert H M Van Tol; James L Kennedy
Journal:  Biol Psychiatry       Date:  2004-07-01       Impact factor: 13.382

2.  A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.

Authors:  Uhna Sung; Subramaniam Apparsundaram; Aurelio Galli; Kristopher M Kahlig; Valentina Savchenko; Sally Schroeter; Michael W Quick; Randy D Blakely
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

3.  Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter.

Authors:  Gonzalo E Torres; Ana Carneiro; Katie Seamans; Chiara Fiorentini; Ava Sweeney; Wei-Dong Yao; Marc G Caron
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

4.  Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.

Authors:  Richard Nass; David H Hall; David M Miller; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A.

Authors:  S L Deken; M L Beckman; L Boos; M W Quick
Journal:  Nat Neurosci       Date:  2000-10       Impact factor: 24.884

6.  The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs.

Authors:  Hanne Hastrup; Namita Sen; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

7.  Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter.

Authors:  Ki-Hwan Lee; Mi-Young Kim; Dong-Hwan Kim; Yong-Sung Lee
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

8.  Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1.

Authors:  Paul W McDonald; Shannon L Hardie; Tammy N Jessen; Lucia Carvelli; Dawn Signor Matthies; Randy D Blakely
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

9.  Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.

Authors:  Susan L Ingram; Balakrishna M Prasad; Susan G Amara
Journal:  Nat Neurosci       Date:  2002-10       Impact factor: 24.884

10.  Regulating the conducting states of a mammalian serotonin transporter.

Authors:  Michael W Quick
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

View more
  46 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.

Authors:  M A Cervinski; J D Foster; R A Vaughan
Journal:  Neuroscience       Date:  2010-07-17       Impact factor: 3.590

3.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

Review 4.  Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.

Authors:  Louis J De Felice; Richard A Glennon; Sidney S Negus
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

5.  S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

Authors:  Aldo A Rodriguez-Menchaca; Ernesto Solis; Krasnodara Cameron; Louis J De Felice
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

6.  An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Authors:  Rheaclare Fraser; Yongyue Chen; Bipasha Guptaroy; Kathryn D Luderman; Stephanie L Stokes; Asim Beg; Louis J DeFelice; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2014-04-21       Impact factor: 4.436

7.  Proline-directed phosphorylation of the dopamine transporter N-terminal domain.

Authors:  Balachandra K Gorentla; Amy E Moritz; James D Foster; Roxanne A Vaughan
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

8.  Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions.

Authors:  Amaia M Erdozain; Stéphanie De Gois; Véronique Bernard; Victor Gorgievski; Nicolas Pietrancosta; Sylvie Dumas; Carlos E Macedo; Peter Vanhoutte; Jorge E Ortega; J Javier Meana; Eleni T Tzavara; Vincent Vialou; Bruno Giros
Journal:  Neuropsychopharmacology       Date:  2017-09-14       Impact factor: 7.853

9.  Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats.

Authors:  Lin Chen; Xinbing Wei; Yunfeng Hou; Xiaoqian Liu; Senpeng Li; Baozhu Sun; Xinyong Liu; Huiqing Liu
Journal:  Neurochem Int       Date:  2014-01-22       Impact factor: 3.921

10.  Subcellular localization of the antidepressant-sensitive norepinephrine transporter.

Authors:  Heinrich J G Matthies; Qiao Han; Angela Shields; Jane Wright; Jessica L Moore; Danny G Winder; Aurelio Galli; Randy D Blakely
Journal:  BMC Neurosci       Date:  2009-06-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.